Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1 Butylbiguanide
2. 1-butylbiguanide
3. Adebit
4. Buformin
5. Butylbiguanide
6. Gliporal
7. Retard, Silubin
8. Silubin
9. Silubin Retard
1. 1190-53-0
2. Buformin Hcl
3. Buformine Hcl
4. N-butyl Biguanide Hydrochloride
5. Silubin
6. Buformin (hydrochloride)
7. Panformin
8. Sindiatil
9. 1-butylbiguanide Hydrochloride
10. 15537-73-2
11. Biforon
12. Diabrin
13. Adebit
14. Andere
15. Butylbiguanide Hydrochloride
16. Dbv Hydrochloride
17. Butyl Guanylguanidine
18. Buformin Hydrochloride [jan]
19. N-butylimidodicarbonimidic Diamide Hydrochloride
20. 2-butyl-1-(diaminomethylidene)guanidine;hydrochloride
21. Nsc-113665
22. Nsc-528218
23. Imidodicarbonimidicdiamide, N-butyl-, Hydrochloride (1:1)
24. Sb 103
25. Imidodicarbonimidic Diamide, N-butyl-, Hydrochloride (1:)
26. D947sxo87p
27. Nsc113665
28. 1-butyl-3-carbamimidoylguanidine;hydrochloride
29. W37
30. Butyl-biguanide Hydrochloride
31. Imidodicarbonimidic Diamide, N-butyl-, Hydrochloride
32. Dibetos-b (tn)
33. Buformin Hydrochloride (jp17)
34. 1-n-butylbiguanide Hydrochloride
35. Hy-b2099a
36. Dtxsid50922844
37. Imidodicarbonimidic Diamide, N-butyl-, Hydrochloride (1:1)
38. Buformin Hydrochloride [mi]
39. 2-pyrrolidin-1-ylmethyl-acrylicacid
40. Einecs 239-587-5
41. Mfcd00045591
42. Nsc528218
43. Akos005256824
44. Buformin Hydrochloride [who-dd]
45. As-11601
46. Db-041440
47. B6007
48. Cs-0106137
49. Ft-0633441
50. 1-butyl-3-carbamimidoyl-guanidine Hydrochloride
51. D02206
52. 190b530
53. A910589
54. Buformin Hydrochloride 100 Microg/ml In Methanol
55. J-004063
56. Buformin Hydrochloride 100 Microg/ml In Acetonitrile
57. N-[amino(butylamino)methylidene]guanidine Hydrochloride
58. Q27276263
59. Z1691545036
60. N-butyltriimidodicarbonic Diamide--hydrogen Chloride (1/1)
61. N'-butyl-1-[(diaminomethylidene)amino]methanimidamide Hydrochloride
| Molecular Weight | 193.68 g/mol |
|---|---|
| Molecular Formula | C6H16ClN5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Exact Mass | 193.1094232 g/mol |
| Monoisotopic Mass | 193.1094232 g/mol |
| Topological Polar Surface Area | 103 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 156 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Hypoglycemic Agents
Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)
ABOUT THIS PAGE
A 1190-53-0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1190-53-0, including repackagers and relabelers. The FDA regulates 1190-53-0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1190-53-0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1190-53-0 supplier is an individual or a company that provides 1190-53-0 active pharmaceutical ingredient (API) or 1190-53-0 finished formulations upon request. The 1190-53-0 suppliers may include 1190-53-0 API manufacturers, exporters, distributors and traders.
click here to find a list of 1190-53-0 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1190-53-0 Drug Master File in Japan (1190-53-0 JDMF) empowers 1190-53-0 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1190-53-0 JDMF during the approval evaluation for pharmaceutical products. At the time of 1190-53-0 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1190-53-0 suppliers with JDMF on PharmaCompass.
1190-53-0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1190-53-0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1190-53-0 GMP manufacturer or 1190-53-0 GMP API supplier for your needs.
A 1190-53-0 CoA (Certificate of Analysis) is a formal document that attests to 1190-53-0's compliance with 1190-53-0 specifications and serves as a tool for batch-level quality control.
1190-53-0 CoA mostly includes findings from lab analyses of a specific batch. For each 1190-53-0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1190-53-0 may be tested according to a variety of international standards, such as European Pharmacopoeia (1190-53-0 EP), 1190-53-0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1190-53-0 USP).
LOOKING FOR A SUPPLIER?
